Literature DB >> 11103881

Exaggerated MK-801-induced motor hyperactivity in rats with the neonatal lesion of the ventral hippocampus.

H A Al-Amin1, D R Weinberger, B K Lipska.   

Abstract

Neonatal lesions of the ventral hippocampus in rats produce changes in spontaneous and pharmacologically induced dopamine-dependent behaviors that emerge in early adulthood. Neural mechanisms underlying these changes may have implications for understanding the neurobiology of schizophrenia, putatively a neurodevelopmental disorder. In this study, we evaluated the effects of MK-801 (dizocilpine), on automated measures of distance traveled and stereotypies in adult rats with neonatal (postnatal day 7) lesions, and tested the effects of haloperidol, clozapine and an alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic (AMPA) antagonist LY293558 on the MK-801-induced behaviors. The lesioned rats showed significantly greater increases in motor activity after 0.05 and O.1 mg/kg of MK-801 than did controls. Both haloperidol (0.1 and 0.4 mg/kg) and clozapine (4 and 10 mg/kg) reduced hyperlocomotion elicited by 0.2 mg/kg MK-801 in the ventral hippocampus (VH)-lesioned and sham rats. Haloperidol was more potent than clozapine in decreasing MK-801-induced stereotypy, especially in the lesioned rats. Moreover, an AMPA antagonist normalized exaggerated MK-801-induced hyperolocomotion in the lesioned rats at doses that had no effect in controls. These results demonstrate that the lesioned rats are more sensitive to MK-801 during adulthood than control rats, and that antidopaminergic drugs as well as AMPA antagonists antagonize the MK-801-induced behaviors. The neonatal lesion rat model may be useful to further our understanding of the interactions between dopamine and glutamate and their role in the pathophysiology of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11103881     DOI: 10.1097/00008877-200006000-00010

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  22 in total

1.  Delayed mesolimbic system alteration in a developmental animal model of schizophrenia.

Authors:  Yukiori Goto; Patricio O'Donnell
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

2.  A neurodevelopmental model of schizophrenia: neonatal disconnection of the hippocampus.

Authors:  Barbara K. Lipska; Daniel R. Weinberger
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

3.  Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia.

Authors:  Tsuyoshi Miyakawa; Lorene M Leiter; David J Gerber; Raul R Gainetdinov; Tatyana D Sotnikova; Hongkui Zeng; Marc G Caron; Susumu Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-08       Impact factor: 11.205

4.  Developmental vitamin D deficiency alters MK-801-induced behaviours in adult offspring.

Authors:  James P Kesby; Jonathan C O'Loan; Suzanne Alexander; Chao Deng; Xu-Feng Huang; John J McGrath; Darryl W Eyles; Thomas H J Burne
Journal:  Psychopharmacology (Berl)       Date:  2011-09-21       Impact factor: 4.530

5.  Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia.

Authors:  Céline Risterucci; Karine Jeanneau; Stephanie Schöppenthau; Thomas Bielser; Basil Künnecke; Markus von Kienlin; Jean-Luc Moreau
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

Review 6.  Animal models of schizophrenia.

Authors:  C A Jones; D J G Watson; K C F Fone
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

7.  SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit.

Authors:  J-P Terranova; C Chabot; M-C Barnouin; G Perrault; R Depoortere; G Griebel; B Scatton
Journal:  Psychopharmacology (Berl)       Date:  2005-04-14       Impact factor: 4.530

8.  Risperidone pretreatment prevents elevated locomotor activity following neonatal hippocampal lesions.

Authors:  Neil M Richtand; Benjamin Taylor; Jeffrey A Welge; Rebecca Ahlbrand; Michelle M Ostrander; Jeffrey Burr; Scott Hayes; Lique M Coolen; Laurel M Pritchard; Aaron Logue; James P Herman; Robert K McNamara
Journal:  Neuropsychopharmacology       Date:  2006-01       Impact factor: 7.853

9.  Vitamin A depletion alters sensitivity of motor behavior to MK-801 in C57BL/6J mice.

Authors:  Ming Zhang; Baohu Ji; Hong Zou; Junwei Shi; Zhao Zhang; Xingwang Li; Hui Zhu; Guoyin Feng; Meilei Jin; Lei Yu; Lin He; Chunling Wan
Journal:  Behav Brain Funct       Date:  2010-01-22       Impact factor: 3.759

10.  Prenatal protein deprivation alters dopamine-mediated behaviors and dopaminergic and glutamatergic receptor binding.

Authors:  Abraham A Palmer; Alan S Brown; Debbra Keegan; Lara DeSanti Siska; Ezra Susser; John Rotrosen; Pamela D Butler
Journal:  Brain Res       Date:  2008-07-30       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.